Cellulitis  >>  Cubicin (daptomycin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT02052388: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Completed
2
215
US
Daptomycin, Cubicin, Brilacidin, PMX63
Cellceutix Corporation
Skin Infection, Bacterial Infection
10/14
10/14

Download Options